Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $4.52 Million - $5.06 Million
-35,577 Closed
0 $0
Q2 2019

Aug 02, 2019

SELL
$131.15 - $144.24 $23,607 - $25,963
-180 Reduced 0.5%
35,577 $4.96 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $77,946 - $86,669
-620 Reduced 1.7%
35,757 $5 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $70,018 - $84,268
-570 Reduced 1.54%
36,377 $4.69 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $24,316 - $28,576
-200 Reduced 0.54%
36,947 $5.11 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $6,505 - $7,703
52 Added 0.14%
37,147 $4.76 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $82,668 - $90,480
-630 Reduced 1.67%
37,095 $5.18 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $4.88 Million - $5.11 Million
37,725
37,725 $4.91 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Eliot Finkel Investment Counsel, LLC Portfolio

Follow Eliot Finkel Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eliot Finkel Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eliot Finkel Investment Counsel, LLC with notifications on news.